Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
Galectin Therapeutics Inc (NASDAQ: GALT) closed the day trading at $3.15 down -1.56% from the previous closing price of $3.2. In other words, the price has decreased by -$1.56 from its previous closing price. On the day, 0.67 million shares were traded. GALT stock price reached its highest trading level at $3.185 during the session, while it also had its lowest trading level at $2.94.
On August 13, 2020, H.C. Wainwright reiterated its Buy rating and also lowered its target price recommendation from $9 to $12.
On February 13, 2019, B. Riley FBR started tracking the stock assigning a Buy rating and target price of $11.B. Riley FBR initiated its Buy rating on February 13, 2019, with a $11 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 06 ’26 when LEWIS JOEL sold 37,698 shares for $3.58 per share. The transaction valued at 134,853 led to the insider holds 832,592 shares of the business.
LEWIS JOEL sold 27,731 shares of GALT for $108,342 on Jan 05 ’26. The President and CEO now owns 870,290 shares after completing the transaction at $3.91 per share. On Jan 02 ’26, another insider, LEWIS JOEL, who serves as the President and CEO of the company, sold 18,571 shares for $4.20 each. As a result, the insider received 77,939 and left with 898,021 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GALT now has a Market Capitalization of 203109504 and an Enterprise Value of 319831296.
Stock Price History:
The Beta on a monthly basis for GALT is 1.01, which has changed by 1.8378379 over the last 52 weeks, in comparison to a change of 0.19362879 over the same period for the S&P500. Over the past 52 weeks, GALT has reached a high of $7.13, while it has fallen to a 52-week low of $1.07. The 50-Day Moving Average of the stock is -39.63%, while the 200-Day Moving Average is calculated to be -9.72%.
Shares Statistics:
Over the past 3-months, GALT traded about 520.15K shares per day on average, while over the past 10 days, GALT traded about 528860 shares per day. A total of 64.47M shares are outstanding, with a floating share count of 45.57M. Insiders hold about 29.33% of the company’s shares, while institutions hold 16.05% stake in the company. Shares short for GALT as of 1765756800 were 5950487 with a Short Ratio of 11.44, compared to 1763078400 on 6757137. Therefore, it implies a Short% of Shares Outstanding of 5950487 and a Short% of Float of 13.059999999999999.
Earnings Estimates
The dynamic stock of Galectin Therapeutics Inc (GALT) is currently being evaluated by a team of 1.0 analysts, each contributing to its current rating.
Analysts are recommending an EPS of between -$0.49 and -$0.49 for the fiscal current year, implying an average EPS of -$0.49. EPS for the following year is -$0.41, with 1.0 analysts recommending between -$0.41 and -$0.41.
